Prism Medico and Pharmacy Limited (BOM:512217)
India · Delayed Price · Currency is INR 29.78
+0.04 (0.13%)
At close: Sep 11, 2026
Prism Medico and Pharmacy Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Apr '24 Apr 1, 2024 | Apr '23 Apr 1, 2023 | Apr '22 Apr 1, 2022 |
Operating Revenue | 8.55 | 24.43 | 6.32 | 29.25 | 12.71 | 84.44 |
Other Revenue | - | - | - | 0 | - | 0 |
| 8.55 | 24.43 | 6.32 | 29.25 | 12.71 | 84.44 | |
Revenue Growth | -60.39% | 286.68% | -78.40% | 130.21% | -84.95% | -49.63% |
Cost of Revenue | 7.11 | 15.69 | 4.49 | 25.61 | 11.41 | 86.28 |
Gross Profit | 1.43 | 8.75 | 1.83 | 3.65 | 1.3 | -1.84 |
Selling, General & Admin | 4.72 | 4.64 | 2.6 | 5.02 | 2.27 | 3.06 |
Other Operating Expenses | -0.54 | -0.24 | -0.08 | - | -0.02 | - |
Operating Expenses | 4.21 | 4.43 | 2.56 | 5.08 | 2.32 | 3.15 |
Operating Income | -2.78 | 4.31 | -0.73 | -1.43 | -1.02 | -4.99 |
Interest Expense | -0 | - | - | -0.07 | -0 | -0.01 |
Interest & Investment Income | - | 0.02 | - | - | - | - |
Currency Exchange Gain (Loss) | -0 | -0 | 0.09 | - | - | - |
Other Non Operating Income (Expenses) | -0.01 | -0.03 | -0.02 | 1.22 | -0 | 0 |
EBT Excluding Unusual Items | -2.79 | 4.3 | -0.66 | -0.28 | -1.02 | -4.99 |
Pretax Income | -2.79 | 4.3 | -0.66 | -0.28 | -1.02 | -4.99 |
Income Tax Expense | 1.18 | 1.11 | -0.17 | -0.07 | -0.26 | -1.29 |
Net Income | -3.97 | 3.18 | -0.49 | -0.21 | -0.76 | -3.7 |
Net Income to Common | -3.97 | 3.18 | -0.49 | -0.21 | -0.76 | -3.7 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 15 | 6 | 6 | 4 | 6 | 6 |
Shares Outstanding (Diluted) | 15 | 6 | 6 | 4 | 6 | 6 |
Shares Change | - | - | 41.67% | -27.08% | -3.21% | 0.01% |
EPS (Basic) | -0.27 | 0.53 | -0.08 | -0.05 | -0.13 | -0.61 |
EPS (Diluted) | -0.27 | 0.53 | -0.08 | -0.05 | -0.13 | -0.61 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Apr '24 Apr 1, 2024 | Apr '23 Apr 1, 2023 | Apr '22 Apr 1, 2022 |
Gross Margin | 16.78% | 35.79% | 29.02% | 12.46% | 10.23% | -2.18% |
Operating Margin | -32.48% | 17.65% | -11.54% | -4.89% | -8.01% | -5.90% |
Profit Margin | -46.47% | 13.03% | -7.71% | -0.73% | -6.00% | -4.38% |
EBITDA | -2.74 | 4.35 | -0.69 | -1.38 | -0.95 | -4.9 |
EBITDA Margin | -32.09% | 17.79% | -10.87% | -4.71% | -7.49% | -5.80% |
D&A For EBITDA | 0.03 | 0.04 | 0.04 | 0.05 | 0.07 | 0.09 |
EBIT | -2.78 | 4.31 | -0.73 | -1.43 | -1.02 | -4.99 |
EBIT Margin | -32.48% | 17.65% | -11.54% | -4.89% | -8.01% | -5.90% |
Effective Tax Rate | - | 25.89% | - | - | - | - |
Revenue as Reported | 9.71 | 24.7 | 6.48 | 30.48 | 12.72 | 84.44 |
Advertising Expenses | - | 0.27 | 0.17 | - | - | - |